{"entity":{"type":"insider","cik":"0001528831","url":"/insider/0001528831","json_url":"/insider/0001528831.json","name":"Tatsutani Kristine N","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":7,"first":"2013-01-16","last":"2013-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Tatsutani Kristine N","source":"filing","n_filings":7,"first_seen":"2013-01-16","last_seen":"2013-08-05"}],"transactions":[{"id":5026543,"accession":"0001181431-13-042882","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-042882","line_url":"/filing/0001181431-13-042882#line-3","is_derivative":false,"issuer_cik":"0001415336","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001415336","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg.,Clinical & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11352.0,"shares_display":"11,352","price_per_share":7.0,"price_display":"7.00","price_state":"stated","total_value":79464.0,"total_display":"79,464.00","total_whole":"79,464","shares_owned_after":30769.0,"shares_owned_after_display":"30,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-01","filed_date":"2013-08-05","scope":"insider"},{"id":9252977,"accession":"0001181431-13-035926","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-035926","line_url":"/filing/0001181431-13-035926#line-2","is_derivative":false,"issuer_cik":"0001528831","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001528831","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg.,Clinical & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4413.0,"shares_display":"4,413","price_per_share":5.8,"price_display":"5.80","price_state":"stated","total_value":25595.4,"total_display":"25,595.40","total_whole":"25,595","shares_owned_after":30769.0,"shares_owned_after_display":"30,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-06-20","scope":"insider"},{"id":5026535,"accession":"0001181431-13-042882","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-042882","line_url":"/filing/0001181431-13-042882#line-1","is_derivative":false,"issuer_cik":"0001415336","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001415336","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg.,Clinical & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11352.0,"shares_display":"11,352","price_per_share":8.24,"price_display":"8.24","price_state":"stated","total_value":93540.48,"total_display":"93,540.48","total_whole":"93,540","shares_owned_after":30769.0,"shares_owned_after_display":"30,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-17","filed_date":"2013-08-05","scope":"insider"},{"id":9252976,"accession":"0001181431-13-035926","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-035926","line_url":"/filing/0001181431-13-035926#line-1","is_derivative":false,"issuer_cik":"0001528831","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001528831","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg.,Clinical & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14127.0,"shares_display":"14,127","price_per_share":5.8,"price_display":"5.80","price_state":"stated","total_value":81936.6,"total_display":"81,936.60","total_whole":"81,937","shares_owned_after":30769.0,"shares_owned_after_display":"30,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-20","scope":"insider"},{"id":4626335,"accession":"0001181431-13-035639","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-035639","line_url":"/filing/0001181431-13-035639#line-4","is_derivative":false,"issuer_cik":"0001415336","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001415336","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg.,Clinical & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14127.0,"shares_display":"14,127","price_per_share":5.8,"price_display":"5.80","price_state":"stated","total_value":81936.6,"total_display":"81,936.60","total_whole":"81,937","shares_owned_after":30769.0,"shares_owned_after_display":"30,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-14","filed_date":"2013-06-19","scope":"insider"},{"id":5329047,"accession":"0001181431-13-023335","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-023335","line_url":"/filing/0001181431-13-023335#line-5","is_derivative":false,"issuer_cik":"0001415336","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001415336","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg.,Clinical & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12119.0,"shares_display":"12,119","price_per_share":4.61,"price_display":"4.61","price_state":"stated","total_value":55868.59,"total_display":"55,868.59","total_whole":"55,869","shares_owned_after":30769.0,"shares_owned_after_display":"30,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-23","filed_date":"2013-04-24","scope":"insider"},{"id":4626324,"accession":"0001181431-13-035639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-035639","line_url":"/filing/0001181431-13-035639#line-1","is_derivative":false,"issuer_cik":"0001415336","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001415336","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg.,Clinical & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4413.0,"shares_display":"4,413","price_per_share":5.8,"price_display":"5.80","price_state":"stated","total_value":25595.4,"total_display":"25,595.40","total_whole":"25,595","shares_owned_after":30769.0,"shares_owned_after_display":"30,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-23","filed_date":"2013-06-19","scope":"insider"},{"id":5329040,"accession":"0001181431-13-023335","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-023335","line_url":"/filing/0001181431-13-023335","is_derivative":false,"issuer_cik":"0001415336","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001415336","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg.,Clinical & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg.,Clinical & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6775.0,"shares_display":"6,775","price_per_share":4.6,"price_display":"4.60","price_state":"stated","total_value":31165.0,"total_display":"31,165.00","total_whole":"31,165","shares_owned_after":31848.0,"shares_owned_after_display":"31,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-22","filed_date":"2013-04-24","scope":"insider","n_lines":2},{"id":4888407,"accession":"0001209191-13-013896","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-013896","line_url":"/filing/0001209191-13-013896#line-2","is_derivative":false,"issuer_cik":"0001415336","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001415336","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg., Clinic & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg., Clinic & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg., Clinic & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2700.0,"shares_display":"2,700","price_per_share":4.68,"price_display":"4.68","price_state":"stated","total_value":12636.0,"total_display":"12,636.00","total_whole":"12,636","shares_owned_after":31848.0,"shares_owned_after_display":"31,848","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-01","filed_date":"2013-03-05","scope":"insider"},{"id":4699122,"accession":"0001209191-13-004823","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-004823","line_url":"/filing/0001209191-13-004823#line-2","is_derivative":false,"issuer_cik":"0001415336","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001415336","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg., Clinic & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg., Clinic & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg., Clinic & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3520.0,"shares_display":"3,520","price_per_share":4.6,"price_display":"4.60","price_state":"stated","total_value":16192.0,"total_display":"16,192.00","total_whole":"16,192","shares_owned_after":32692.0,"shares_owned_after_display":"32,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-25","filed_date":"2013-01-29","scope":"insider"},{"id":4247166,"accession":"0001209191-13-003238","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-003238","line_url":"/filing/0001209191-13-003238#line-4","is_derivative":false,"issuer_cik":"0001415336","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001415336","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg., Clinic & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg., Clinic & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg., Clinic & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7343.0,"shares_display":"7,343","price_per_share":4.6787,"price_display":"4.68","price_state":"stated","total_value":34355.6941,"total_display":"34,355.69","total_whole":"34,356","shares_owned_after":32692.0,"shares_owned_after_display":"32,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-15","filed_date":"2013-01-16","scope":"insider"},{"id":4247161,"accession":"0001209191-13-003238","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-003238","line_url":"/filing/0001209191-13-003238#line-2","is_derivative":false,"issuer_cik":"0001415336","issuer_name":"Zeltiq Aesthetics Inc","issuer_ticker":"ZLTQ","issuer_name_source":null,"issuer_url":"/issuer/0001415336","owner_cik":"0001528831","owner_name":"Tatsutani Kristine N","owner_display_name":"Tatsutani Kristine N","owner_url":"/insider/0001528831","role":"Officer (CSO, SVP of Reg., Clinic & QA)","role_mark":"O","role_mark_label":"Officer (CSO, SVP of Reg., Clinic & QA)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CSO, SVP of Reg., Clinic & QA","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4008.0,"shares_display":"4,008","price_per_share":4.8609,"price_display":"4.86","price_state":"stated","total_value":19482.4872,"total_display":"19,482.49","total_whole":"19,482","shares_owned_after":32692.0,"shares_owned_after_display":"32,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-14","filed_date":"2013-01-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001415336","name":"Zeltiq Aesthetics Inc","url":"/issuer/0001415336","role":"Officer (CSO, SVP of Reg.,Clinical & QA)","n_filings":7,"first_seen":"2013-01-16","last_seen":"2013-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001528831","retrieved_at":"2026-08-27T05:00:28+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}